Palantir Technologies Inc.
I · AI Analysis
The brief
Palantir creates software that helps governments and businesses make sense of massive amounts of data. Their main products include Gotham (for defense and intelligence work), Foundry (for corporate data integration), and Apollo (for software deployment). They recently added AI capabilities that work with large language models to help analyze both structured and unstructured data.
Palantir Technologies is a software company that builds data analysis platforms primarily for government agencies (defense, intelligence) and large corporations. The company is highly profitable with strong growth, but trades at an extremely high valuation that reflects investor expectations for continued expansion.
Palantir is exceptionally profitable with explosive growth, though it trades at a premium valuation.
Sentinellis health
10/10
Financially healthy
Market capitalisation
$354.0B
Revenue (TTM)
$4.5B
II · Recent news
What moved
3 stories · ranked by relevance
- macro2026-04-16
Palantir Technologies (NASDAQ:PLTR) Trading 2.5% Higher – Still a Buy?
Watch List News
- macro2026-04-16
Palantir Paid No Federal Income Tax in 2025 as It Partnered With ICE, Pentagon
Truthout
- macro2026-04-16
From PayPal to Palantir: What Peter Thiel's Track Record Means for Patient Shareholders Today
Yahoo Finance
Premium · Free with any account
Extreme valuation risk: at 235x earnings, the stock price assumes many years of perfect execution and leaves little room for disappointment [Yahoo Finance]
Risks
4
Opportunities
4
Red flags
2
Leadership
10
9 more findings in the full report — free with any account.
Unlock the full Palantir Technologies Inc. analysis
Create a free account to access the complete AI-generated report with inline citations.
- 4 risks, 4 opportunities and 2 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Technology or comparable health
Want this for your watchlist?